The Impact of Vitamin D Status on Preoperative Ultrasound Findings and Parathyroidectomy Outcomes in Patients With Primary Hyperparathyroidism

Ashutosh Surya, Peter N. Taylor, Hussam Abusahmin, Onyebuchi Okosieme, Gautam Das


Background: An impaired vitamin D status may present with an aggressive phenotype of primary hyperparathyroidism (PHPT). We evaluated the impact of 25-hydroxyvitamin D (25(OH)D3) levels on pre-operative ultrasound findings and outcomes following parathyroidectomy.

Methods: Retrospective analysis of 81 patients who had parathyroidectomy for PHPT from January 2008 to October 2016. Patients were grouped according to their 25(OH)D3 levels (deficient (< 30 nmol/L), insufficient (? 30 and < 50 nmol/L), sufficient (? 50 nmol/L)). All patients had preoperative ultrasound scans (USS) and their pre-and post-operative biochemistry results and pathology reports were obtained from the hospital portal system.

Results: Preoperatively, there was no statistically significant difference in parathyroid hormone (PTH) (P = 0.19) and adjusted calcium (P = 0.91) levels in different vitamin D subgroups. Parathyroidectomy led to significant improvement of PTH, adjusted calcium, phosphate, alkaline phosphatase and creatinine levels (P < 0.00001). USS did not show any significant difference in localizing single gland disease (SGD) in vitamin D subgroups (sensitivity 57.1%, 62.5% and 55.8% in deficient, insufficient and sufficient groups respectively) and the chances of finding a negative scan was similar in all groups (about 44.5%). USS could not detect any multiple gland disease (MGD). Inferiorly located glands were more involved especially when 25(OH)D3 levels were in the deficient or insufficient range. Postoperatively, patients had higher adenoma weight in vitamin D deficient and insufficient groups (1.42 ± 1.35 g and 1.11 ± 1.39 g) compared to sufficient group (0.58 ± 0.48 g) for SGD and trend was identical for the combined weight of glands in MGD (1.81 ± 2.79 g; 0.93 ± 0.58 g and 0.59 ± 0.33 g respectively). Regression analysis showed an inverse association of 25(OH)D3 level with adenoma weight for SGD (r = -0.006; P = 0.008) but not when multiple glands were resected (r = -0.0007; P = 0.54).

Conclusions: Vitamin D does not influence biochemical severity of disease in PHPT. USS is a reliable tool for localization in SGD but ineffective for MGD and the sensitivity and specificity of scan results are not affected by vitamin D levels. Hypovitaminosis D leads to higher adenoma weight and an inverse relationship exists between the two for SGD.

J Endocrinol Metab. 2017;7(6):172-177



Vitamin D; Ultrasound; Primary hyperparathyroidism; Parathyroidectomy; Single gland disease; Multiple gland disease

Full Text: HTML PDF
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe



Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board



Company Profile

Editorial Office

Misconduct and Retraction


Company Registration

Contact Us

Abstracting and Indexing



Instructions to Authors


Declaration of Helsinki

Contact Publisher

Submission Checklist


Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy


Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians


Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal


Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.